Poljak, Mario
University of Ljubljana
14 papers on CoChatORCID 0000-0002-3216-7564
Most cited papers
- Verified
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine
Cervical Cancer and HPV ResearchWomen's cancer prevention and management
Cited by 897
- Verified
Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis
Bruni, L., Serrano, B., Roura, E., Alemany, L., Cowan, M., Herrero, R., Poljak, M., Murillo, R., Broutet, N., Riley, L. M., et al. (2022) · The Lancet Global Health
Cervical Cancer and HPV ResearchWomen's cancer prevention and management
Cited by 558
- Verified
2020 list of human papillomavirus assays suitable for primary cervical cancer screening
Arbyn, M., Simon, M., Peeters, E., Xu, L., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Bonde, J., Ostrbenk Vanlencak, A., Zhao, F.-H., et al. (2021) · Clinical Microbiology and Infection
Cervical Cancer and HPV ResearchWomen's cancer prevention and management
Cited by 284
- Verified
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Arbyn, M., Snijders, P. J. F., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Kocjan, B. J., & Poljak, M. (2015) · Clinical Microbiology and Infection
Cervical Cancer and HPV ResearchWomen's cancer prevention and management
Cited by 275
- Verified
Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17
Deshpande, A., Miller-Petrie, M. K., Lindstedt, P. A., Baumann, M. M., Johnson, K. B., Blacker, B. F., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abdollahpour, I., et al. (2020) · The Lancet Global Health
Child Nutrition and Water AccessWater Resource Management and Quality
Cited by 187
- Verified
VALGENT: a protocol for clinical validation of human papillomavirus assays
Arbyn, M., Depuydt, C., Benoy, I., Bogers, J., Cuschieri, K., Schmitt, M., Pawlita, M., Geraets, D., Heard, I., Gheit, T., et al. (2016) · Journal of Clinical Virology
Cervical Cancer and HPV ResearchClinical Laboratory Practices and Quality Control
Cited by 157
- Verified
Transmission of Mycobacterium tuberculosis from Human to Cattle
Ocepek, M., Pate, M., Žolnir-Dovč, M., & Poljak, M. (2005) · Journal of Clinical Microbiology
Tuberculosis Research and EpidemiologyMycobacterium research and diagnosis
Cited by 136
- Verified
Mapping routine measles vaccination in low- and middle-income countries
Collaborators, L. B. O. D. V. C., Sbarra, A. N., Rolfe, S., Nguyen, J. Q., Earl, L., Galles, N. C., Marks, A., Abbas, K. M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2021) · Nature
Vaccine Coverage and HesitancyVirology and Viral Diseases
Cited by 125
- Verified
The contribution of Mycoplasma genitalium to the aetiology of sexually acquired infectious proctitis in men who have sex with men.
Bissessor, M., Tabrizi, S. N., Bradshaw, C. S., Fairley, C. K., Hocking, J. S., Garland, S. M., Twin, J., Poljak, M., Peel, J., & Chen, M. Y. (2016) · Clinical Microbiology and Infection
Reproductive tract infections researchMicrobial infections and disease research
Cited by 99
- Verified
Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis
Erdem, H., Cag, Y., Ozturk-Engin, D., Defres, S., Kaya, S., Larsen, L., Poljak, M., Barsic, B., Argemi, X., Sørensen, S. M., et al. (2015) · Antimicrobial Agents and Chemotherapy
Herpesvirus Infections and TreatmentsInfectious Encephalopathies and Encephalitis
Cited by 74
- Verified
Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework
Xu, L., Oštrbenk, A., Poljak, M., & Arbyn, M. (2018) · Journal of Clinical Virology
Cervical Cancer and HPV ResearchWomen's cancer prevention and management
Cited by 45
- Verified
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework
Oštrbenk, A., Xu, L., Arbyn, M., & Poljak, M. (2018) · Journal of Clinical Microbiology
Cervical Cancer and HPV ResearchReproductive tract infections research
Cited by 34
- Verified
Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities
Cornall, A. M., Poljak, M., Garland, S. M., Phillips, S., Tan, J. H., Machalek, D. A., Quinn, M. A., & Tabrizi, S. N. (2017) · European Journal of Clinical Microbiology & Infectious Diseases
Cervical Cancer and HPV ResearchReproductive tract infections research
Cited by 22
- Verified
Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening
Oštrbenk Valenčak, A., Cuschieri, K., Connor, L., Zore, A., Smrkolj, Š., & Poljak, M. (2024) · Journal of Clinical Virology
Cervical Cancer and HPV ResearchWomen's cancer prevention and management
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free